It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Medical information request
Medical information request

Medical information requests

If you have any questions or concerns related to safety of fingolimod, please contact Novartis Medical Information (MI) experts for evidence-based up-to-date information

Do you have a question ?
Click here

 

Using this webpage, you may also report an adverse event or product complaint

Report an adverse event

border
* Indication wording varies in different countries. The current website is a global information resource. Local Prescribing Information/ Summary of Product Characteristics approved by individual country’s regulatory authority is the primary source of information for the indication of fingolimod in the individual country.